Interestingly, in a recent publication, we reported a similar mechanism in which LAPTM4B suppresses proteasomal degradation of SLC7A11, thereby counteracting ferroptosis in NSCLC 23. Here, LAPTM4B is linked to non-small cell lung carcinoma.